Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

338
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
338
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

249
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
249
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RBMX functional retrocopy safeguards brain development in a species-dependent context.

Brain : a journal of neurology·2026
Same author

PMX-CovEval: A Framework Including a Simulated Pharmacokinetic Database for Covariate Model Building Methods Benchmarking.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Cdk7 promotes neuritogenesis in cortical neurons and contributes to social behavior in mice.

Cellular and molecular life sciences : CMLS·2026
Same author

Developmental gene expression patterns driving species-specific cortical features.

Nature·2026
Same author

Protocol for whole-cell patch-clamp recording and post hoc identification of hippocampal CA2 pyramidal neurons in adult mouse brain slices.

STAR protocols·2026
Same author

Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort.

International journal of chronic obstructive pulmonary disease·2026

Related Experiment Video

Updated: Jan 18, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

Integrating Population Approaches With Physiologically Based Pharmacokinetic Models: A Novel Framework for Parameter

Donato Teutonico1, David Marchionni2, Marc Lavielle3,4

  • 1Pharmacometrics, Translational Medicine Unit, Sanofi, Vitry-sur-Seine, France.

CPT: Pharmacometrics & Systems Pharmacology
|January 16, 2026
PubMed
Summary

This study introduces a new population method for Physiologically Based Pharmacokinetic (PBPK) models, improving parameter estimation and reducing computational time. The approach enhances drug development by leveraging individual data for more accurate pharmacokinetic predictions.

Keywords:
PBPKSAEMindividual variabilityphysiologically based pharmacokineticspopPBPKpopWB‐PBPK

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

Related Experiment Videos

Last Updated: Jan 18, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

Area of Science:

  • Pharmacokinetics and Drug Development
  • Computational Biology and Bioinformatics
  • Systems Pharmacology

Background:

  • Physiologically Based Pharmacokinetic (PBPK) modeling is crucial for predicting drug concentrations during development.
  • Estimating parameters in PBPK models is challenging due to numerous parameters and limited data.
  • Existing methods struggle to efficiently estimate inter-individual variability in physiologically relevant parameters.

Purpose of the Study:

  • To introduce a novel population whole-body PBPK (popWB-PBPK) modeling approach for enhanced parameter estimation.
  • To leverage individual patient data for more accurate PBPK model parameterization and variability assessment.
  • To present an optimized Stochastic Approximation Expectation-Maximization (SAEM) algorithm for efficient PBPK parameter estimation.

Main Methods:

  • Coupling whole-body PBPK (WB-PBPK) models with population estimation techniques.
  • Implementing an optimized SAEM algorithm with adaptive parameter grid optimization and linear interpolation.
  • Utilizing theophylline as a case study to estimate drug-specific parameters and covariate effects (e.g., smoking status).

Main Results:

  • The popWB-PBPK approach accurately estimates drug-specific parameters like CYP1A2 clearance and lipophilicity.
  • The optimized SAEM algorithm significantly reduces computational runtime compared to standard SAEM.
  • The method successfully incorporates covariate effects, demonstrating its practical utility.

Conclusions:

  • The developed popWB-PBPK framework provides an accessible R package (saemixPBPK) for robust PBPK parameter estimation.
  • This approach enables simultaneous estimation of population parameters, variability, and uncertainty while preserving physiological relevance.
  • Advancements in mechanistic modeling facilitate more reliable pharmacokinetic predictions using individual data.